Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

60.66

+1.14 (1.92%)

At close: Jun 18, 2026, 4:00 PM EDT

63.00

+2.34 (3.86%)

After-hours: Jun 18, 2026, 7:55 PM EDT

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	608	429	5	6	20	85
Market Cap Growth	150.17%	8742.00%	-18.98%	-70.74%	-75.79%	-
Enterprise Value	389	393	0	0	14	67
Last Close Price	60.66	60.66	1.17	1.60	6.15	35.71
PB Ratio	2.75	7.29	1.19	1.23	2.67	5.51
P/TBV Ratio	2.75	7.29	1.19	1.23	2.67	5.52
Debt / Equity Ratio	0	0.00	0.02	0.01	0.01	-
Net Debt / Equity Ratio	-1.00	-1.01	-1.01	-1.01	-1.09	-1.02
Quick Ratio	81.10	35.68	10.92	24.16	8.00	31.12
Current Ratio	81.48	36.10	11.32	24.26	8.11	31.38
Return on Equity (ROE)	-15.02%	-27.93%	-46.18%	-86.02%	-99.95%	-85.94%
Return on Assets (ROA)	-10.44%	-18.80%	-25.28%	-47.45%	-57.32%	-51.52%
Return on Capital Employed (ROCE)	-10.00%	-16.60%	-47.10%	-109.10%	-138.80%	-44.40%
Earnings Yield	-3.22%	-2.04%	-42.70%	-90.90%	-53.20%	-8.09%
Buyback Yield / Dilution	-42.99%	-59.58%	-15.87%	-50.58%	-37.64%	-148.42%

SEC Filings: 10-K · 10-Q